ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

14,012Medicare Part D Prescriptions Filled, Including Refills

Rank: 265 out of 2888

$955K Total Retail Price of All Prescriptions

Rank: 240 out of 2888

667 Patients Receiving at Least One Drug in Part D
78%Patients 65 Years and Older
70% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Texas
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

2% of this provider’s 667 patients filled at least one prescription for a schedule three drug, compared to an average of 15%.

Risky Drugs to Seniors

3% of this provider’s 11,554 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

30% of this provider’s prescriptions were for brand-name drugs, compared to an average of 27%.

Prescription Price

$68 was the average price of a prescription from this provider, compared to $67 among peers.

Prescriptions per Patient

21 is the average number of prescriptions (including refills) per patient, compared to an average of 19.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Texas
SIMVASTATIN 788 641 1 2
LISINOPRIL 694 575 2 3
AMLODIPINE BESYLATE 532 472 3 5
LEVOTHYROXINE SODIUM 513 433 4 1
LOSARTAN POTASSIUM 430 355 5 18
METFORMIN HCL 429 314 6 8
DIOVAN 355 333 7 35
TRAMADOL HCL-ACETAMINOPHEN 340 292 8 95
OMEPRAZOLE 330 289 9 7
CRESTOR 291 223 10 20
ALENDRONATE SODIUM 278 223 11 23
FUROSEMIDE 261 227 12 6
HYDROCHLOROTHIAZIDE 252 204 13 15
GLYBURIDE-METFORMIN HCL 196 155 R 14 64
GLYBURIDE 190 152 R 15 58
METOPROLOL TARTRATE 184 151 16 10
NEXIUM 168 129 17 19
METOPROLOL SUCCINATE 154 132 18 11
ZOSTAVAX 152 126 19 221
WARFARIN SODIUM 147 145 20 22
ATORVASTATIN CALCIUM 138 114 21 9
CLONIDINE HCL 138 107 21 39
MELOXICAM 135 104 23 31
LANTUS 135 89 23 45
ZOLPIDEM TARTRATE 133 97 25 17
FENOFIBRATE 130 102 26 65
CLOPIDOGREL 126 110 27 30
DIOVAN HCT 118 98 28 61
NIFEDIPINE ER 113 101 29 76
LANTUS SOLOSTAR 112 83 30 92
ACTONEL 111 106 31 149
ZETIA 109 95 32 81
ENALAPRIL MALEATE 107 89 33 49
AZITHROMYCIN 104 84 34 38
PRAVASTATIN SODIUM 103 87 35 12
PLAVIX 97 88 36 40
POTASSIUM CHLORIDE 95 89 37 14
FAMOTIDINE 95 51 37 75
PEN NEEDLE 92 70 39 110
HUMALOG 91 58 40 166
CARVEDILOL 91 81 40 21
GLIPIZIDE 85 71 42 50
DONEPEZIL HCL 84 75 43 26
TAMSULOSIN HCL 80 74 44 29
ATENOLOL 79 68 45 25
JANUVIA 76 61 46 48
INSULIN SYRINGE 75 57 47 86
GLIMEPIRIDE 73 52 48 36
NAPROXEN 72 45 49 80
GABAPENTIN 70 62 50 13
SERTRALINE HCL 69 57 51 27
LYRICA 68 56 52 69
CYCLOBENZAPRINE HCL 66 52 R 53 68
PAROXETINE HCL 65 64 54 84
LOSARTAN-HYDROCHLOROTHIAZIDE 64 48 55 46
CIPROFLOXACIN HCL 62 54 56 47
BYSTOLIC 62 33 56 99
ATELVIA 62 57 56 201
CARAFATE 61 53 59 408
METHYLPREDNISOLONE 58 52 60 101
NOVOLIN R 58 56 60 109
NAMENDA 57 56 62 34
TRAMADOL HCL 56 45 63 16
POLYETHYLENE GLYCOL 3350 55 52 64 93
ISOSORBIDE MONONITRATE ER 55 50 64 51
SULFAMETHOXAZOLE-TRIMETHOPRIM 54 38 66 88
METOCLOPRAMIDE HCL 52 17 67 116
PRANDIN 52 47 67 305
CYMBALTA 51 14 69 44
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on March 17, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.